Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of bevacizumab plus paclitaxel in inoperable metastatic breast cancer
jRCT2080220385Phase 2
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Apr 2007
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, single-arm trial of bevacizumab and paclitaxel in breast cancer, sponsored by Chugai Pharmaceutical Co., Ltd.
02
Drugs
bevacizumabpaclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on jRCT2080220385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220385.